Nisa Investment Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Nisa Investment Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,284	Closed	-$31K	–	2917
2023 Q1	$31K	Buy	1,284 +1,220	+1,906%	+$15.3K	﹤0.01%	1873
2022 Q4	$1K	Buy	+64	New	+$516	﹤0.01%	2561
2022 Q2	–	Sell	-45,400	Closed	-$332K	–	2545
2022 Q1	$332K	Buy	+45,400	New	+$272K	﹤0.01%	1201
2021 Q3	–	Sell	-5,100	Closed	-$43	–	2349
2021 Q2	$43	Buy	+5,100	New	+$41.1K	﹤0.01%	1982

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nisa Investment Advisors's PRVB Position: Q2 2023 in Review

Nisa Investment Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,284 shares — an estimated $31K sold.

Nisa Investment Advisors first reported a position in PRVB in Q2 2021 and held it in 4 quarters. The position peaked at $332K in Q1 2022. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Nisa Investment Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Nisa Investment Advisors sold 1,284 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $31K.
Nisa Investment Advisors first reported a position in Provention Bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Nisa Investment Advisors's Provention Bio, Inc. Common Stock position peaked at $332K in Q1 2022.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Nisa Investment Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.